Methylguanine methyltransferase activity deficiency in immature rat mammary epithelial cells parallels increased carcinogenic susceptibility

Molecular Carcinogenesis

Volumn 44, Issue 3, 2005, Pages 193-201

  Ariazi, Jennifer L ^a,b   Haag, Jill D ^b   Gould, Michael N ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Age factors; Carcinogenesis; Methylguanine methyltransferase; N nitroso N methylurea; Rat mammary gland

Indexed keywords

ANTINEOPLASTIC AGENT; CIGARETTE SMOKE; METHYLGUANINE METHYLTRANSFERASE; METHYLNITROSOUREA; METHYLTRANSFERASE; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; COMET ASSAY; ENZYME DEFICIENCY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CARCINOGENS; CELL DIFFERENTIATION; CELLS, CULTURED; COMET ASSAY; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; FEMALE; MAMMARY NEOPLASMS, ANIMAL; METHYLNITROSOUREA; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 27644538371     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20131     Document Type: Article

References (42)

1. Land CE. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer [see comments]. JAMA 1995;274:402-407.
2. Tokunaga M, Land CE, Yamamoto T, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res 1987;112:243-272.
3. Lash TL, Aschengrau A. Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol 1999;149:5-12.
4. Brunnemann KD, Prokopczyk B, Djordjevic MV, Hoffmann D. Formation and analysis of tobacco-specific N-nitrosamines. Crit Rev Toxicol 1996;26:121-137.
5. Marcus PM, Newman B, Millikan RC, Moorman PG, Baird DD, Qaqish B. The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control 2000;11:271-278.
6. Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: A review of the literature. Cancer Epidemiol Biomarkers Prev 2002;11:953-971.
7. Green DM, Hyland A, Barcos MP, et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 2000;18:1492-1499.
8. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993;85:25-31.
9. Ariazi JL, Haag JD, Lindstrom MJ, Gould MN. Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N-nitroso-N-methylurea. Mol Carcinog 2005;43:155-164.
10. Pegg AE. Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Invest 1984;2:223-231.
11. Fong LY, Jensen DE, Magee PN. DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylnitrosourea. Carcinogenesis 1990;11:411-417.
12. Marra G, Schar P. Recognition of DNA alterations by the mismatch repair system. Biochem J 1999;338:1-13.
13. Krokan HE, Standal R, Slupphaug G. DNA glycosylases in the base excision repair of DNA. Biochem J 1997;325:1-16.
14. O'Connor PJ, Manning FC, Gordon AT, et al. DNA repair: Kinetics and thresholds. Toxicol Pathol 2000;28:375-381.
15. Fortini P, Raspaglio G, Falchi M, Dogliotti E. Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay. Mutagenesis 1996;11:169-175.
16. Fairbairn DW, Olive PL, O'Neill KL. The comet assay: A comprehensive review. Mutat Res 1995;339:37-59.
17. Dolan ME, Moschel RC, Pegg AE. Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 1990;87:5368-5372.
18. Hamdan MA, Guzman RC, Yang J, Beattie C, Mascharack P, Nandi S. Depletion of O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine in three-dimensional collagen cultures of normal human breast epithelial cells. Carcinogenesis 1992;13:1743-1749.
19. Kreklau EL, Limp-Foster M, Liu N, Xu Y, Kelley MR, Erickson LC. A novel fluorometric oligonudeotide assay to measure O(6)-methylguanme DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase. Nucleic Acids Res 2001;29:2558-2566.
20. Kamiya K, Gould MN, Clifton KH. Quantitative studies of ductal versus alveolar differentiation from rat mammary clonogens. Proc Soc Exp Biol Med 1998;219:217-225.
21. Gerson SL, Trey JE, Miller K, Berger NA. Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat, and mouse tissues. Carcinogenesis 1986;7:745-749.
22. Kidney JK, Faustman EM. Modulation of nitrosourea toxicity in rodent embryonic cells by O6-benzylguanine, a depletor of O6-methylguanine-DNA methyltransferase. Toxicol Appl Pharmacol 1995;133:1-11.
23. Nelms BE. Micro-irradiation techniques using synchrotron-produced ultrasoft X-rays: Varying the intracellular dose deposition to study radiobiological mechanisms. PhD Thesis. Madison: University of Wisconsin-Madison; 1997.
24. Apoptosis Assays. In: Spector DL, Goldman RD, Leinwand LA, editors. Cells: A laboratory Manual. Volume 1. USA: Cold Spring Harbor Laboratory Press; 1998. p 15.11-15.19.
25. Kreklau EL, Liu N, Li Z, Cornetta K, Erickson LC. Comparison of single- versus double-bolus treatments of O(6)-benzylguanine for depletion of O(6)-methylguanine DNA methyltransferase (MGMT) activity in vivo: Development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity. J Pharmacol Exp Ther 2001;297:524-530.
26. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982;2:5-73.
27. Mirzayans R, Middlestadt MV, Paterson MC. Cytotoxic and mutagenic effects of methylnitrosourea in two human fetal fibroblast strains differing in O6-methylguanine-DNA methyltransferase activity. Carcinogenesis 1992;13:1185-1190.
28. Kalamegham R, Warmels-Rodenhiser S, MacDonald H, Ebisuzaki K. O6-methylguanine-DNA methyltransferase-defective human cell mutant: O6-methylguanine, DNA strand breaks and cytotoxicity. Carcinogenesis 1988;9:1749-1753.
29. Shimada Y, Yasukawa-Barnes J, Kim RY, Gould MN, Clifton KH. Age and radiation sensitivity of rat mammary clonogenic cells [published erratum appears in Radiat Res 1994 Jul;139(1):128] [see comments]. Radiat Res 1994;137:118-123.
30. Grombacher T, Mitra S, Kaina B. Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes. Carcinogenesis 1996;17:2329-2336.
31. Grombacher T, Eichhorn U, Kaina B. p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene 1998;17:845-851.
32. Sharma PM, Bowman M, Yu BF, Sukumar S. A rodent model for Wilms tumors: Embryonal kidney neoplasms induced by N-nitroso-N′-methylurea. Proc Natl Acad Sci USA 1994;91:9931-9935.
33. Grombacher T, Kaina B. Constitutive expression and inducibility of O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in rat liver cells exhibiting different status of differentiation. Biochim Biophys Acta 1995;1270:63-72.
34. Choy KW, Pang CP, To KF, Yu CB, Ng JS, Lam DS. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues. Invest Ophthalmol Vis Sci 2002;43:1344-1349.
35. Yin D, Xie D, Hofmann WK, et al. DNA repair gene O6-methylguanine-DNA methyltransferase: Promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors. Mol Carcinog 2003;36:23-31.
36. Esteller M, Risques RA, Toyota M, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001;61:4689-4692.
37. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-797.
38. Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA. O(6)-methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. Cancer Res 2001;61:8113-8117.
39. Watts GS, Pieper RO, Costello JF, Peng YM, Dalton WS, Futscher BW. Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol 1997;17:5612-5619.
40. Sugimura T, Ushijima T. Genetic and epigenetic alterations in carcinogenesis. Mutat Res 2000;462:235-246.
41. Haorah J, Zhou L, Wang X, Xu G, Mirvish SS. Determination of total N-nitroso compounds and their precursors in frankfurters, fresh meat, dried salted fish, sauces, tobacco, and tobacco smoke particulates. J Agric Food Chem 2001;49:6068-6078.
42. Lijinsky W. N-nitroso compounds in the diet. Mutat Res 1999;443:129-138.